Tricyclic antidepressant plasma levels after augmentation with citalopram: a case study.

Détails

ID Serval
serval:BIB_8BB8D7C83428
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Tricyclic antidepressant plasma levels after augmentation with citalopram: a case study.
Périodique
European journal of clinical pharmacology
Auteur⸱e⸱s
Baettig D., Bondolfi G., Montaldi S., Amey M., Baumann P.
ISSN
0031-6970 (Print)
ISSN-L
0031-6970
Statut éditorial
Publié
Date de publication
1993
Peer-reviewed
Oui
Volume
44
Numéro
4
Pages
403-405
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
In a depressed patient, the addition of citalopram 40-60 mg per day to treatment with amitriptyline 75 mg per day had no effect on the plasma levels of amitriptyline and nortriptyline, but it led to clinical improvement without the appearance of adverse effects. This and similar findings in four other patients comedicated with citalopram and amitriptyline (2 patients), clomipramine or maprotiline suggest that citalopram differs from other selective serotonin reuptake inhibitors, such as fluvoxamine and fluoxetine, which have been shown to increase tricyclic antidepressant plasma levels.
Mots-clé
Antidepressive Agents, Tricyclic/blood, Antidepressive Agents, Tricyclic/therapeutic use, Citalopram/therapeutic use, Depressive Disorder/blood, Depressive Disorder/drug therapy, Drug Interactions, Drug Therapy, Combination, Female, Humans, Middle Aged
Pubmed
Web of science
Création de la notice
12/01/2021 17:16
Dernière modification de la notice
15/04/2023 6:51
Données d'usage